Literature DB >> 8839443

Ascorbate uptake by microvascular endothelial cells of rat skeletal muscle.

J X Wilson1, S J Dixon, J Yu, S Nees, K Tyml.   

Abstract

OBJECTIVE: In several systems, exogenous ascorbate (reduced vitamin C) has been shown to protect against microvascular injury induced by reactive oxygen species. Since skeletal muscle is relatively resistant to oxidative injury, it is possible that under physiological conditions endogenous ascorbate in the muscle microvasculature affords such protection. To examine the ability of microvascular endothelium to accumulate ascorbate, we aimed (1) to develop an in vitro model of microvascular endothelial cells derived from rat hindlimb skeletal muscles and (2) to investigate the uptake and steady-state concentration of ascorbate in these cells.
METHODS: Microvascular cells were enzymatically dissociated, isolated on a density gradient, and grown in serum-supplemented medium. After passaging, they were tested for formation of tube-like structures, coagulation factor VIII antigen expression, Griffonia simplicifolia lectin I-isolectin B4 binding, and acetylated low-density lipoprotein (LDL) uptake. Concentrations of reduced ascorbate were measured by high-performance liquid chromatography (HPLC) with electrochemical detection. Transport activity was assessed on the basis of the initial rate [14C]ascorbate uptake.
RESULTS: The cultured cells tested positively for factor VIII antigen expression, lectin binding, LDL uptake, and tube formation. Although these cells did not synthesize ascorbate de novo, they accumulated reduced vitamin C when it was added to the culture medium. The initial rate of [14C]ascorbate uptake was 0.9 mumol/g cell protein 10 min when cells were incubated with 10 microM of the radiolabeled vitamin. This uptake was Na+-dependent and was blocked by the organic anion transport inhibitor sulfinpyrazone, but was not acutely affected by glucose. Following incubation with a physiological concentration of vitamin C (100 microM L-ascorbate), cells accumulated a high concentration of ascorbate within 6 h (approximately 16 mM at steady-state). Steady-state cellular ascorbate concentration was also dependent on extracellular Na+ and sensitive to sulfinpyrazone.
CONCLUSIONS: Microvascular cells derived from rat hindlimb muscles demonstrated endothelial characteristics. These cells accumulated reduced vitamin C by means of Na+-dependent ascorbate transporters, which are distinct from hexose carriers. The high endothelial ascorbate concentration at steady-state is consistent with the role of ascorbate as a major antioxidant in the skeletal muscle microvasculature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839443     DOI: 10.3109/10739689609148290

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  12 in total

1.  Reduction of electrical coupling between microvascular endothelial cells by NO depends on connexin37.

Authors:  Rebecca L McKinnon; Michael L Bolon; Hong-Xing Wang; Scott Swarbreck; Gerald M Kidder; Alexander M Simon; Karel Tyml
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

2.  Ascorbate uptake in pig coronary artery endothelial cells.

Authors:  Kelly A Best; Melanie E Holmes; Sue E Samson; James Mwanjewe; John X Wilson; S Jeffrey Dixon; Ashok K Grover
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

3.  Dehydroascorbic acid uptake by coronary artery smooth muscle: effect of intracellular acidification.

Authors:  Melanie E Holmes; James Mwanjewe; Sue E Samson; James V Haist; John X Wilson; S Jeffrey Dixon; Morris Karmazyn; Ashok K Grover
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

4.  Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases.

Authors:  Jianjie Wang; Susan Bingaman; Virginia H Huxley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-05       Impact factor: 4.733

5.  Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction.

Authors:  Feng Wu; John X Wilson
Journal:  Cardiovasc Res       Date:  2008-09-13       Impact factor: 10.787

6.  Ascorbate protects endothelial barrier function during septic insult: Role of protein phosphatase type 2A.

Authors:  Min Han; Suresh Pendem; Suet Ling Teh; Dinesh K Sukumaran; Feng Wu; John X Wilson
Journal:  Free Radic Biol Med       Date:  2009-10-17       Impact factor: 7.376

7.  Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.

Authors:  Richard G E Archer; Václav Pitelka; James R Hammond
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

8.  Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Karel Tyml; Fuyan Li; John X Wilson
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

9.  iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells.

Authors:  Feng Wu; Karel Tyml; John X Wilson
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

10.  Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation.

Authors:  Feng Wu; Min Han; John X Wilson
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.